CapsoVision (CV) Stock Forecast: StockMap's 2-Week Call
CV stock forecast: StockMap's model makes no two-week call on CapsoVision after the Nov 19 close: its evidence is split, 3 reasons for and 12 against. Right in 1 of 6 two-week windows on CV since Aug 21; by chance, a call on the same dates was right 59% of the time.
CapsoVision last closed at $6.31, -7.48% on the session.
Against the IVW growth benchmark the position is -5.15% over the forecast window.
CapsoVision's market cap is $338.27M as of November 19, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -10 (too close to call).
Where CV sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 3 bullish and 12 bearish.
Agreement across those insights is 80%.
25 daily calls for CV so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks CapsoVision in the 6th percentile on return on equity, where 100 is best.
CapsoVision is classified under Health Care / Health Care Equipment & Supplies.
StockMap tracks CapsoVision as the 81st largest of the 141 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.
Across that group the current two-week reads are 69 Neutral, 55 Moderate Underperform, 14 Strong Underperform and 3 Moderate Outperform.
On that composite CapsoVision ranks 52nd of 141 in the group, against a group median of -0.18.